{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:44:11Z","timestamp":1785365051518,"version":"3.55.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Plant Sci."],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed more than 37,000 people in Italy and has caused widespread socioeconomic disruption. Urgent measures are needed to contain and control the virus, particularly diagnostic kits for detection and surveillance, therapeutics to reduce mortality among the severely affected, and vaccines to protect the remaining population. Here we discuss the potential role of plant molecular farming in the rapid and scalable supply of protein antigens as reagents and vaccine candidates, antibodies for virus detection and passive immunotherapy, other therapeutic proteins, and virus-like particles as novel vaccine platforms. We calculate the amount of infrastructure and production capacity needed to deal with predictable subsequent waves of COVID-19 in Italy by pooling expertise in plant molecular farming, epidemiology and the Italian health system. We calculate the investment required in molecular farming infrastructure that would enable us to capitalize on this technology, and provide a roadmap for the development of diagnostic reagents and biopharmaceuticals using molecular farming in plants to complement production methods based on the cultivation of microbes and mammalian cells.<\/jats:p>","DOI":"10.3389\/fpls.2020.609910","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:15:15Z","timestamp":1607926515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Plant Molecular Farming as a Strategy Against COVID-19 \u2013 The Italian Perspective"],"prefix":"10.3389","volume":"11","author":[{"given":"Chiara","family":"Lico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Baschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Marusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Donini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pedrazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Franconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Di Bonito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Avesani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.plaphy.2016.06.029","article-title":"Purification of recombinant tissue plasminogen activator (rtPA) protein from transplastomic tobacco plants.","volume":"108","author":"Abdoli Nasab","year":"2016","journal-title":"Plant Physiol. Biochem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/dmp.2020.149","article-title":"COVID-19: are we ready for the second wave?","volume":"7","author":"Ali","year":"2020","journal-title":"Disaster Med. Public Health Prep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans.","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1467-7652.2010.00514.x","article-title":"Recombinant human GAD65 accumulates to high levels in transgenic tobacco plants when expressed as an enzymatically inactive mutant.","volume":"8","author":"Avesani","year":"2010","journal-title":"Plant Biotech. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1016\/s0264-410x(03)00360-8","article-title":"Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen.","volume":"21","author":"Bae","year":"2003","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002685","article-title":"Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells.","volume":"3","author":"Bai","year":"2008","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.addr.2018.08.007","article-title":"Use of plant viruses and virus-like particles for the creation of novel vaccines.","volume":"145","author":"Balke","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1467-7652.2008.00342.x","article-title":"Anchorage to the cytosolic face of the ER membrane: a new strategy to stabilize a cytosolic recombinant antigen in plants.","volume":"6","author":"Barbante","year":"2008","journal-title":"Plant Biotech. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/rth2.12357","article-title":"Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: scientific rationale and review.","volume":"4","author":"Barrett","year":"2020","journal-title":"Res. Pract. Thromb Haemost."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2516","article-title":"Diagnostic accuracy of serological tests for COVID-19: systematic review and meta-analysis.","volume":"370","author":"Bastos","year":"2020","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.biotechadv.2017.03.011","article-title":"Very large-scale production of antibodies in plants: the bioligization of manufacturing.","volume":"35","author":"Buyel","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.tplants.2020.04.009","article-title":"Potential applications of plant biotechnology against SARS-CoV-2.","volume":"25","author":"Capell","year":"2020","journal-title":"Trends Plant Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jmv.20338","article-title":"Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS.","volume":"76","author":"Carattoli","year":"2005","journal-title":"J. Med. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/21645515.2020.1740560","article-title":"Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.","volume":"16","author":"Chen","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1467-7652.2008.00384.x","article-title":"Influenza virus\u2212like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.","volume":"6","author":"D\u2019Aoust","year":"2008","journal-title":"Plant Biotechnol. J."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2016.01148","article-title":"Molecular farming: fast, scalable, cheap, sustainable.","volume":"7","author":"De Martinis","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2016.00054","article-title":"Antigen production in plant to tackle infectious diseases flare up: the case of SARS.","volume":"7","author":"Demurtas","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00472","article-title":"High level production of monoclonal antibodies using an optimized plant expression system.","volume":"17","author":"Diamos","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10529-019-02651-z","article-title":"Current state-of-the-art in plant-based antibody production systems.","volume":"41","author":"Donini","year":"2019","journal-title":"Biotechnol. Lett."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107519","article-title":"Molecular farming\u2013the slope of enlightenment.","volume":"40","author":"Fischer","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.biotechadv.2011.08.007","article-title":"GMP issues for recombinant plant-derived pharmaceutical proteins.","volume":"30","author":"Fischer","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-024-1263-5_10","article-title":"Rapid and low-cost tools derived from plants to face emerging\/re-emerging infectious diseases and bioterrorism agents","author":"Franconi","year":"2018","journal-title":"Defence against Bioterrorism. NATO Science for Peace and Security Series A: Chemistry and Biology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.24.057323","article-title":"Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance.","author":"Freeman","year":"2020","journal-title":"bioRxiv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-015-0120-5","article-title":"Improving the large scale purification of the HIV microbicide, griffithsin.","volume":"15","author":"Fuqua","year":"2015","journal-title":"BMC Biotechnol."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00393","article-title":"Robot cookies\u2013plant cell packs as an automated high-throughput screening platform based on transient expression.","volume":"8","author":"Gengenbach","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/785382","article-title":"Plant virus expression vector development: new perspectives.","volume":"2014","author":"Hefferon","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11103-018-0744-7","article-title":"High-level expression of the HIV entry inhibitor griffithsin from the plastid genome and retention of biological activity in dried tobacco leaves.","volume":"97","author":"Hoelscher","year":"2018","journal-title":"Plant Mol. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/pbi.12469","article-title":"Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals.","volume":"13","author":"Holtz","year":"2015","journal-title":"Plant Biotechnol. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/vim.2005.18.668","article-title":"Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.","volume":"18","author":"Huang","year":"2005","journal-title":"Viral Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/bit.22652","article-title":"High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system.","volume":"106","author":"Huang","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","article-title":"Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.","volume":"24","author":"Huang","year":"2006","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2015.00655","article-title":"Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials.","volume":"6","author":"Jantan","year":"2015","journal-title":"Front. Plant Sci."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104236","article-title":"Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.","volume":"145","author":"Kalitaa","year":"2020","journal-title":"Microbial Pathogen."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033010","article-title":"Transient expression of hemagglutinin antigen from low pathogenic avian influenza A (H7N7) in nicotiana benthamiana.","volume":"7","author":"Kanagarajan","year":"2012","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026920.)","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine.","volume":"2020","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.antiviral.2007.03.003","article-title":"Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle.","volume":"75","author":"Keyaerts","year":"2007","journal-title":"Antiviral Res."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.21.20109280","article-title":"Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling.","author":"Klumpp-Thomas","year":"2020","journal-title":"medRxiv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.prrv.2020.06.010","article-title":"Vaccines for COVID-19: the current state of play.","volume":"35","author":"Koirala","year":"2020","journal-title":"Paediatric Respir. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1073\/pnas.96.14.7774","article-title":"Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.","volume":"96","author":"Koo","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.vaccine.2003.11.066","article-title":"A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine.","volume":"22","author":"Lamphear","year":"2004","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2217\/EBO.11.73","author":"Lico","year":"2011","journal-title":"Influenza Vaccines: New Perspectives from Plants. Plant-derived Vaccines: Technologies &amp; Applications."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1016\/j.vaccine.2009.06.045","article-title":"Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice.","volume":"27","author":"Lico","year":"2009","journal-title":"Vaccine"},{"key":"B47","author":"Lico","year":"","journal-title":"Plant-based Vaccine Delivery Strategies Innovation in Vaccinology: from Design, through to Delivery and Testing."},{"key":"B48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00299-011-1215-7","article-title":"The use of plants for the production of therapeutic human peptides.","volume":"31","author":"Lico","year":"","journal-title":"Plant Cell Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.2174\/09298673113209990035","article-title":"Nanoparticles in biomedicine: new insights from plant viruses.","volume":"20","author":"Lico","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.26241","article-title":"Antibody responses against SARS-CoV-2 in COVID-19 patients.","volume":"30","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.vaccine.2007.11.092","article-title":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV.","volume":"26","author":"Lokugamage","year":"2008","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19.","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00425-012-1692-0","article-title":"In planta production of a candidate vaccine against bovine papillomavirus type 1.","volume":"236","author":"Love","year":"2012","journal-title":"Planta"},{"key":"B55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2567.2010.03231.x","article-title":"Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.","volume":"130","author":"Lu","year":"2010","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2567.2007.02676.x","article-title":"Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice.","volume":"122","author":"Lu","year":"2007","journal-title":"Immunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.01378","article-title":"Production and immunogenicity of soluble plant-produced HIV-1 subtype C envelope gp140 immunogens.","volume":"10","author":"Margolin","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.01674","article-title":"Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen.","volume":"16","author":"Marques","year":"2020","journal-title":"Front. Plant Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.copbio.2015.12.007","article-title":"Molecular pharming-VLPs made in plants.","volume":"37","author":"Marsian","year":"2016","journal-title":"Curr. Opin. Biotech."},{"key":"B60","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.1128\/JVI.75.18.8434-8439.2001","article-title":"Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.","volume":"75","author":"Marusic","year":"2001","journal-title":"J. Virol."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-11-106","article-title":"Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.","volume":"11","author":"Mati\u0107","year":"2011","journal-title":"BMC Biotechnol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00782","article-title":"From farm to finger prick\u2014a perspective on how plants can help in the fight against COVID-19 front.","volume":"8","author":"McDonald","year":"2020","journal-title":"Bioeng. Biotechnol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential.","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of ebola virus disease therapeutics.","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","article-title":"Techno-economic analysis of a transient plant-based platform for monoclonal antibody production.","volume":"8","author":"Nandi","year":"2016","journal-title":"MABS"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family coronaviridae.","volume":"84","author":"O\u2019Keefe","year":"2010","journal-title":"J. Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1073\/pnas.0901506106","article-title":"Scalable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.","volume":"106","author":"O\u2019Keefe","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00253-004-1869-y","article-title":"Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination.","volume":"68","author":"Pei","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120751","article-title":"Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.","volume":"10","author":"Peyret","year":"2015","journal-title":"PLoS One"},{"key":"B71","author":"Pierlorenzi","year":"2010","journal-title":"L\u2019italia si Misura."},{"key":"B72","doi-asserted-by":"publisher","first-page":"16547","DOI":"10.1039\/c8nr02861c","article-title":"Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage.","volume":"10","author":"Pitek","year":"2018","journal-title":"Nanoscale"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1016\/j.vaccine.2020.06.066","article-title":"Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.","volume":"38","author":"Ren","year":"2020","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1467-7652.2009.00425.x","article-title":"Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cells.","volume":"6","author":"Rigano","year":"2009","journal-title":"Plant Biotech. J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19.","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.02.20120477","article-title":"Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA.","author":"Rosendal","year":"2020","journal-title":"medRxiv"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1001\/jama.2020.21106","article-title":"The challenges of expanding rapid tests to curb COVID-19.","volume":"324","author":"Rubin","year":"2020","journal-title":"JAMA"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013976","article-title":"Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody.","volume":"5","author":"Sainsbury","year":"2010","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.01273","article-title":"Plant-made Bet V1 for molecular diagnosis.","volume":"10","author":"Santoni","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/1389203721666200212100255","article-title":"Plant virus nanoparticles for vaccine applications.","volume":"21","author":"Santoni","year":"2020","journal-title":"Curr. Protein Pept. Sci."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.09.20148429","article-title":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection.","author":"Seow","year":"2020","journal-title":"medRxiv"},{"key":"B83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4161\/hv.7.0.14561","article-title":"Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza.","author":"Shoji","year":"2011","journal-title":"Human Vaccines"},{"key":"B84","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.antiviral.2011.12.012","article-title":"A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.","volume":"94","author":"Struck","year":"2011","journal-title":"Antiviral Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1134\/S0026893319030154","article-title":"Virus-Like particles as an instrument for Vaccine production.","volume":"53","author":"Syomin","year":"2019","journal-title":"Mol. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.2174\/1381612811319310011","article-title":"The use of transient expression systems for the rapid production of virus-like particles in plants.","volume":"19","author":"Thuenemann","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B87","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.","author":"Tortorici","year":"2020","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0264-410X(99)00525-3","article-title":"Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants.","volume":"18","author":"Tuboly","year":"2000","journal-title":"Vaccine"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.594019","article-title":"The emergency response capacity of plant-based biopharmaceutical manufacturing \u2013 what it is and what it could be.","volume":"11","author":"Tus\u00e9","year":"2020","journal-title":"Front. Plant Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emer. Microb. Infect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.antiviral.2016.12.019","article-title":"Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.","volume":"140","author":"Wang","year":"2017","journal-title":"Antiviral Res."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses.","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41587-020-0654-5","article-title":"Agtech infrastructure for pandemic preparedness.","volume":"38","author":"Webb","year":"2020","journal-title":"Nat. Biotech."},{"key":"B95","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1128\/JVI.78.13.7217-7226.2004","article-title":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.","volume":"78","author":"Zhou","year":"2004","journal-title":"J. Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/biot.201500255","article-title":"Overcoming low yields of plant-made antibodies by a protein engineering approach.","author":"Zischewski","year":"2016","journal-title":"Biotechnol. J."}],"container-title":["Frontiers in Plant Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpls.2020.609910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:15:19Z","timestamp":1607926519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpls.2020.609910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":95,"alternative-id":["10.3389\/fpls.2020.609910"],"URL":"https:\/\/doi.org\/10.3389\/fpls.2020.609910","relation":{},"ISSN":["1664-462X"],"issn-type":[{"value":"1664-462X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"article-number":"609910"}}